Takeda

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.

Tcr Therapeutics Inc is a biotechnology company based in Cambridge, MA, specializing in the development of novel T cell therapies for the treatment of cancer and autoimmune diseases. With a focus on leveraging the power of the immune system, Tcr Therapeutics Inc aims to advance cutting-edge research and innovation in the field of cellular immunotherapy. Generated from their business information

Metamark Genetics, based in Cambridge, offers an innovative website mirror utility called HTTrack. This user-friendly tool allows users to download entire websites from the Internet to a local directory, including all structures, html, images, and other files. With HTTrack, users can easily create local mirror sites that work seamlessly with any browser, enabling smooth navigation and browsing. The utility is fully configurable and supports the mirroring of multiple sites simultaneously, making it a versatile solution for managing online content. Generated from their website's infomation